Regeneron Pharma (REGN) PT Raised to $540 at Argus
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $618.95 +2.66%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Argus analyst Jasper Hellweg raised the price target on Regeneron Pharma (NASDAQ: REGN) to $540.00 (from $430.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Nitto Denko (6988:JP) (NDEKY) PT Lowered to JPY3,400 at Nomura/Instinet
- Goldman Sachs Upgrades Plains All American (PAA) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
